Related content

Correlation of symptomatic improvements with functional improvements and patient-reported outcomes in adults with attention-deficit/hyperactivity disorder treated with OROS methylphenidate

By Rösler Michael  

World Journal of Biological Psychiatry, Vol. 14, Iss. 4, 2013-05 ,pp. : 282-290

Informa Healthcare

Access to resources Recommend Favorite

Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder

By Aron A.R.   Dowson J.H.   Sahakian B.J.   Robbins T.W.  

Biological Psychiatry, Vol. 54, Iss. 12, 2003-12 ,pp. : 1465-1468

Elsevier

Access to resources Recommend Favorite

Neuropsychological Functioning of Adults with Attention Deficit Hyperactivity Disorder

By Walker Alexandra Y.   Shores Arthur E.   Trollor Julian N.   Lee Teresa   Sachdev Perminder S.  

Journal of Clinical and Experimental Neuropsychology (Neuropsychology, Developm, Vol. 22, Iss. 1, 2000-02 ,pp. : 115-124

Routledge Ltd

Access to resources Recommend Favorite

Bupropion SR vs. Methylphenidate vs. Placebo for Attention Deficit Hyperactivity Disorder in Adults

By Kuperman S.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 13, Iss. 3, 2001-09 ,pp. : 129-134

Springer Publishing Company

Access to resources Recommend Favorite

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

By Rösler Michael   Fischer Roland   Ammer Richard   Ose Claudia   Retz Wolfgang  

European Archives of Psychiatry and Clinical Neuroscience, Vol. 259, Iss. 2, 2009-02 ,pp. : 120-129

Springer Publishing Company

Access to resources Recommend Favorite